⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28819858 | 0.80 | KMT2A (0.37) | — | |
| SCHEMBL347377 | 0.80 | — | — | |
| SCHEMBL347376 | 0.80 | — | — | |
| SCHEMBL5734851 | 0.80 | — | — | |
| SCHEMBL1269435 | 0.76 | TSHR (0.32) | — | |
| SCHEMBL17662651 | 0.76 | — | — | |
| SCHEMBL21518220 | 0.76 | HSD17B10 (0.30) | — | |
| SCHEMBL8852428 | 0.76 | — | — | |
| SCHEMBL6550083 | 0.76 | TSHR (0.35) | — | |
| SCHEMBL13778440 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1258247-A1 | Adenosine analogues for the treatment of insulin resistance syndrome and diabetes | Aventis Pharma Deutschland GmbH (DE) | 2002-11-20 | — | — | EP | disclosed |
| US-6331506-B1 | Disubstituted methylidene hydrazinophenyl sulfonylureas, process for their production and their use as herbicides and plant growth regulators | HOECHST SCHERING AGREVO GMBH (DE) | 2001-12-18 | — | — | US | disclosed |
| US-4060402-A | HERBICIDE | SANKYO COMPANY LIMITED (JA) | 1977-11-29 | — | — | US | disclosed |